tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Compare Contineum Therapeutics, Inc. Class A (CTNM) vs. Competitors

Compare
212 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$13.34
$517.02M
-5.28
79.06%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.17
$29.74M
-16.53
-80.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$28.90
$1.66B
-12.77
144.60%
8 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$6.84
$603.75M
-9.36
157.89%
2 Buy
1 Hold
0 Sell
Moderate Buy
Immuneering
$4.96
$320.68M
-5.17
198.80%
5 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$6.37
$426.72M
-5.39
34.11%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
13.34
6.36
91.12%
TVRD
Tvardi Therapeutics
3.17
-12.04
-79.16%
CAPR
Capricor Therapeutics
28.90
19.41
204.53%
DRTS
Alpha Tau Medical Ltd
6.86
4.35
173.31%
IMRX
Immuneering
4.96
3.44
226.32%
ENGN
enGene Holdings
6.37
1.89
42.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts